Consensus Takeda Pharmaceutical Company Limited

Stocks

4502

JP3463000004

Pharmaceuticals

Delayed Japan Exchange 21:37:02 2026-09-24 EDT			5-day change	1st Jan Change
5,985.00 ^JPY	+1.70%		+0.27%	+23.76%

09-23	Two announcments for Roche
09-23	Roche proposes former Takeda CEO for board seat	RE

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

a2bb6984c8a3ad614ae.UvfPmhYlgH06hDRehCNC10kdrG87jcyKcjiDfDgOInY.G8-F8UxM-BdK_U0cwHYk4g1IwTtWtJrhBm_yDw48EzolhKjTXUbwK2zWcQ~39a2e7d503aec7ab94f0ec64ac16a8cf

Analysts' recommendations: Takeda Pharmaceutical Company Limited

08-31	Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says	MT
07-28	SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target	MT
07-24	China Merchants Starts Takeda Pharmaceutical at Buy with 6,600 Yen Price Target	MT
03-30	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
01-30	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
25-09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
25-08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
25-05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
25-05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	Takeda Pharmaceutical : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
17-09-08	Bayer : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Objective/dr gap
TAKEDA PHARMACEUTICAL COMPANY LIMITED		+10.96%
ELI LILLY AND COMPANY		+15.15%
JOHNSON & JOHNSON		+3.25%
ABBVIE INC.		+5.1%
ROCHE HOLDING AG		+3.34%
NOVARTIS AG		+6.94%
ASTRAZENECA PLC	-	+28.29%
AMGEN INC.		-4.15%
GILEAD SCIENCES, INC.		+4.81%
NOVO NORDISK A/S		+21.93%
Average		+9.56%
Weighted average by Cap.		+9.49%